mRNA癌症疫苗:构建和促进策略
Xiaoqing Liu1,2,3, Pei Huang2,3,4, Rusen Yang1
1School of Advanced Materials and Nanotechnology, Xidian University, Xi'an 710126 China.
ACS nano
|October 11, 2023
概括
使者RNA (mRNA) 癌症疫苗在治疗固体瘤方面表现有前途. 研究重点是优化疫苗成分和输送策略,以提高疗效,克服未来癌症治疗的临床挑战.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 美国食品和药物管理局对COVID-19 mRNA疫苗的批准加速了对mRNA疗法的研究.
- 在mRNA癌症疫苗开发方面取得了重大进展,在临床试验中显示出针对各种固体瘤的有希望的结果.
研究的目的:
- 审查优化mRNA癌症疫苗的组件和策略.
- 讨论临床实践中mRNA癌症疫苗的挑战和未来方向.
主要方法:
- 介绍关键的mRNA癌症疫苗组件:mRNA抗原,辅助剂和输送载体.
- 讨论提高疗效的策略,包括调节瘤微环境,优化管理,向治疗和组合治疗.
主要成果:
- 工程mRNA疫苗组件可以提高稳定性,免疫性和输送效率.
- 像调节瘤微环境和组合疗法等策略可以加强抗瘤效应.
结论:
- mRNA癌症疫苗具有临床癌症治疗的巨大潜力.
- 预计在不久的将来,持续的研发将加速它们的临床应用.
关键词:
一个辅助的辅助者.管理路径的管理路径.癌症免疫疗法免疫疗法组合疗法治疗组合治疗.在mRNA癌症疫苗的使用中.提供mRNA传递载体的mRNA.有针对性的交付目标.瘤抗原是一种瘤抗原.瘤微环境是一个微环境.更多相关视频
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
1.8K
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
590
相关概念视频
Cancer Vaccines
384
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
384
Tumor Immunotherapy
539
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
539
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Vaccinations
44.6K
Overview
44.6K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Microorganisms in Medicine and Therapeutics
36
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
36
